From Medscape Oncology

Coverage from the

European Hematology Association (EHA) 2021 Annual Meeting

June 09 - 17, 2021; Virtual/Online

June 09 - 17, 2021 Virtual/Online
  • EHA 2021 Luspatercept Benefit Also in Non-Transfusion-Dependent Thalassemia Patients with beta thalassemia who are not dependent on transfusions also derive benefit from the drug, showing improved hemoglobin levels and a reduced need for blood transfusions.
  • EHA 2021 Zanubrutinib Better Than Ibrutinib in CLL/SLL? An interim phase 3 clinical trial analysis shows encouraging progression-free survival and lower cardiac toxicity in patients with relapsed/refractory chronic lymphocytic leukemia (CLL).

Conference News

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.



Popular News from EHA 2020

Previous Coverage